Robert J. May

Array ( [id] => 7136043 [patent_doc_number] => 20040043948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Antisense modulation of interleukin 8 expression' [patent_app_type] => new [patent_app_number] => 09/960143 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25182 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043948.pdf [firstpage_image] =>[orig_patent_app_number] => 09960143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856714 [patent_doc_number] => 20030130215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Isolated genomic polynucleotide fragments from chromosome 7' [patent_app_type] => new [patent_app_number] => 09/957956 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15170 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20030130215.pdf [firstpage_image] =>[orig_patent_app_number] => 09957956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017690 [patent_doc_number] => 20020103366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Deprotection of RNA' [patent_app_type] => new [patent_app_number] => 09/957841 [patent_app_country] => US [patent_app_date] => 2001-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5744 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103366.pdf [firstpage_image] =>[orig_patent_app_number] => 09957841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766122 [patent_doc_number] => 20030100522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Antisense modulation of ribonuclease L expression' [patent_app_type] => new [patent_app_number] => 09/954679 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25589 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100522.pdf [firstpage_image] =>[orig_patent_app_number] => 09954679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6860995 [patent_doc_number] => 20030092003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Method and reagent for the treatment of Alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 09/930423 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 56569 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092003.pdf [firstpage_image] =>[orig_patent_app_number] => 09930423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1034539 [patent_doc_number] => 06875749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-05 [patent_title] => 'Methods of facilitating vascular growth' [patent_app_type] => utility [patent_app_number] => 09/928796 [patent_app_country] => US [patent_app_date] => 2001-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 8385 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/875/06875749.pdf [firstpage_image] =>[orig_patent_app_number] => 09928796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861639 [patent_doc_number] => 20030092647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Antisense modulation of cholesteryl ester transfer protein expression' [patent_app_type] => new [patent_app_number] => 09/925139 [patent_app_country] => US [patent_app_date] => 2001-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26112 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092647.pdf [firstpage_image] =>[orig_patent_app_number] => 09925139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870594 [patent_doc_number] => 20030083284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Antisense modulation of p70 S6 kinase expression' [patent_app_type] => new [patent_app_number] => 09/920677 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25646 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083284.pdf [firstpage_image] =>[orig_patent_app_number] => 09920677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801608 [patent_doc_number] => 20030096773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Antisense modulation of acyl coenzyme a cholesterol acyltransferase-1 expression' [patent_app_type] => new [patent_app_number] => 09/920394 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26696 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096773.pdf [firstpage_image] =>[orig_patent_app_number] => 09920394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774194 [patent_doc_number] => 20030017532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'ndp' [patent_app_type] => new [patent_app_number] => 09/917382 [patent_app_country] => US [patent_app_date] => 2001-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14073 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017532.pdf [firstpage_image] =>[orig_patent_app_number] => 09917382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870591 [patent_doc_number] => 20030083281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Antisense modulation of PKA regulatory subunit RII beta expression' [patent_app_type] => new [patent_app_number] => 09/915485 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25323 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083281.pdf [firstpage_image] =>[orig_patent_app_number] => 09915485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1043803 [patent_doc_number] => 06867237 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-15 [patent_title] => 'DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans' [patent_app_type] => utility [patent_app_number] => 09/909796 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 31463 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/867/06867237.pdf [firstpage_image] =>[orig_patent_app_number] => 09909796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844308 [patent_doc_number] => 20020132296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Human Ste20-like stress activated serine/threonine kinase' [patent_app_type] => new [patent_app_number] => 09/906397 [patent_app_country] => US [patent_app_date] => 2001-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21798 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132296.pdf [firstpage_image] =>[orig_patent_app_number] => 09906397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922946 [patent_doc_number] => 20020115604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'HCaRG, a novel calcium-regulated gene coding for a nuclear protein' [patent_app_type] => new [patent_app_number] => 09/904568 [patent_app_country] => US [patent_app_date] => 2001-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15450 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115604.pdf [firstpage_image] =>[orig_patent_app_number] => 09904568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801605 [patent_doc_number] => 20030096770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants' [patent_app_type] => new [patent_app_number] => 09/902953 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17265 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096770.pdf [firstpage_image] =>[orig_patent_app_number] => 09902953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1151452 [patent_doc_number] => 06770753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Phosphorothioate antisense heparanase oligonucleotides' [patent_app_type] => B2 [patent_app_number] => 09/899440 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6493 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770753.pdf [firstpage_image] =>[orig_patent_app_number] => 09899440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6783496 [patent_doc_number] => 20030064944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Antisense modulation of transforming growth factor beta receptor II expression' [patent_app_type] => new [patent_app_number] => 09/888361 [patent_app_country] => US [patent_app_date] => 2001-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27292 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064944.pdf [firstpage_image] =>[orig_patent_app_number] => 09888361 [rel_patent_id] =>[rel_patent_doc_number] =>)